MCRB SERES THERAPEUTICS INC Delisting Actions 8-K Filing 2024 - Stock Price Notice Seres Therapeutics reported its financial results for Q3 2024 and received a notice from Nasdaq about its stock price falling below $1.00, giving it until May 6, 2025, to regain compliance.Get access to all SEC 8-K filings of the SERES THERAPEUTICS INC